Elmiron Eye Lawsuit News

Elmiron Eye Lawsuits Inform Others About The Dangers Of Taking The Drug

Women should question the medical advice of their doctors when prescribing Elmiron to treat their bladder pain

Monday, January 31, 2022 - Women who have used the interstitial cystitis drug Elmiron, pentosan polysulfate sodium (PPS) have allegedly experienced severe, debilitating eyesight damage from using the medicine. Plaintiffs are mainly women with bladder pain who have filed Elmiron eye lawsuits against Janssen Pharmaceuticals, the creator of the drug, and their parent company Johnson & Johnson. Urologists have prescribed Elmiron to millions of women with chronic bladder pain over the last 20 years, enjoying a monopoly, without caring about vision damage stemming from taking the drug. Now we know that the two are linked and that the longer a patient takes Elmiron, the greater the vision damage. We have also discovered that vision damage will progressively worsen even after discontinuing taking Elmiron.

Elmiron vision damage is called pigmentary maculopathy, described as when dark spots appear on the back surface of the eye called the retina. A healthy retina is critical for good eyesight. Pigmentary maculopathy causes the field of vision to narrow making it difficult to see in sub-optimal lighting conditions. Plaintiffs allege that they are unable to perform their job, career, or profession because they now have poor eyesight bordering on being legally blind. Recreational enjoyment of life is also hindered by poor eyesight. One woman suing Janssen feared that she would no longer be able to go hiking, her lifetime passion, for fear of being unable to see her footing. Driving at night is impossibly dangerous. All one has to do to get a handle on the level of fraud that the companies may have engaged in by failing to monitor and test Elmiron and ensure its safety is to look at the most recent lawsuit filed against them.

On January 26, 2022, a defective product lawsuit was filed against Janssen Pharmaceuticals for $10 million by Beverly Frizzell, a New Hampshire woman who suffered retinal damage from the long-term use of Elmiron prescribed to treat her bladder pain, according to inforney.com. Inforney reports that more than 600 others have filed similar lawsuits organized into multidistrict litigation in New Jersey federal court. Janssen received reports of Elmiron causing vision damage in 1996 or immediately thereafter. Janssen had an obligation to know or knew about the problems and failed to warn doctors prescribing the drug until 2020. "According to the lawsuit, Janssen was aware of reports soon after Elmiron went on the market in 1996. Clinical studies starting in 2018 documented a link between Elmiron's key ingredients, pentosan polysulfate sodium or PPS, and a condition known as pigmentary maculopathy. Yet a warning label was not issued until 2020," inforney reported. Most who have filed Elmiron eye lawsuits reveal that had they known about the risks of taking the drug every day, presumably for the remainder of their lives, they would choose another treatment. Today women are looking to holistic approaches like eliminating certain foods from their diet, acupuncture, Super Aloe Vera tablets, and following the guidelines put forth by ICHelp.org that stress that eating certain foods may trigger or worsen IC pain.

More Recent Elmiron Eye Lawsuit News:

Lawyers for Elmiron Eye Lawsuits

Attorneys handling Elmiron Eye lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Elmiron Eye lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Elmiron Eye lawsuit. The product liability litigators handling Roundup claims at OnderLaw have a strong track record of success in representing families harmed by dangerous drugs and consumer products.